Piper Sandler Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice TargetHot
Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $98 to $95.
Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $98 to $95.